The Doorstep Moves Again

New Mountain Finance's rate story inverted this quarter; its exit story did not

NMFC · Earnings Call · 2026-11-03

The Doorstep Moves Again

New Mountain Finance reported third-quarter 2026 numbers on November 3, and the headline arithmetic was unremarkable: adjusted net investment income of $0.26 a share covering a $0.25 dividend, net asset value down 2% to $10.67, nonaccruals up 30 basis points to 1.8% at fair value. The interesting part is what management says about the environment rather than itself — because the macro framing has quietly inverted while the strategic framing has not moved an inch.

The one thing that genuinely flipped

For several quarters, this company's keyword set has carried base rate — and tellingly, it has always been paired with "base rate cut." The fear was mechanical and specific: a BDC that lends mostly floating-rate gets paid less when the policy rate falls. That fear is now gone from the script. “At the start of 2026, the forward curve was actually predicting base rate cuts. Today, base rates have remained higher for longer, and the forward curve is now pricing in rate increases over the next 12 months. We believe this creates a tailwind.” — Laura Holson, COO and interim CFO · 2026-11-03 This is not a talking point, it is a duration fact. Roughly 88% of the loan portfolio is floating rate, while liabilities were 77% floating, up from 74% last quarter — Laura Holson noted the company has now “exceeded our target of more than 75% floating rate liabilities.” — Laura Holson, COO and interim CFO · 2026-11-03 Asset-liability matching has been rebuilt precisely so that a higher-for-longer base rate flows to net income instead of being arbitraged away by fixed-rate funding. The floating rate structure is no longer a defensive posture; it is the earnings engine. It also puts NMFC squarely inside a much broader market current. The global keyword tape is dominated this quarter by the same idea — Fed rate hike ranked second across the whole market, alongside the impact of high rates and an outright rate hike cycle. A small-cap BDC and the entire financial sector are now telling the same story, which is exactly what should make an investor suspicious of an idiosyncratic explanation and respectful of a real one. The second mechanical improvement is spreads. Holson described a genuine bifurcation: deals now range “from SOFR plus $4.75 on the tight end to SOFR plus 600s on the wider end,” — Laura Holson, COO and interim CFO · 2026-11-03 versus the flat SOFR-plus-450-to-475 environment that characterized 2025. Portfolio average yield rose to 12%. Even with M&A muted, she attributed it to capital leaving the direct lending market: fewer lenders chasing the same deals, lower leverage, tighter documentation.

The doorstep that keeps receding

Now the tension. The strategic pillar for over a year has been monetizing equity and PIK positions to improve portfolio diversification and cash income quality. The language used to be bold. In May: “we think we're on the doorstep of really transforming the company as we monetize those positions over the next medium-term.” — John Kline, President and CEO · 2026-05-05 In August: “we feel like we're just a couple of moves away from delivering a portfolio that has really great diversity.” — John Kline, President and CEO · 2026-08-04 This quarter the doorstep appears to have moved:

While we have not seen the meaningful pickup that we have been predicting, our deal flow has been steady, particularly in the defensive growth sectors where we focus.
Laura Holson, COO and interim CFO · 2026-11-03

That is an admission, and it matters more than the NAV print. Industry-wide direct lending volume is down roughly 28% year to date per PitchBook, and equity exits — still a top-15 keyword — remain a promise in the pipeline rather than a realized cash event. When analyst Robert Dodd pressed on whether the rotation simply requires a more cooperative M&A activity backdrop, Holson pushed back hard: “I do not think it is so directly tied to the overall volume of M&A environment.” — Laura Holson, COO and interim CFO · 2026-11-03 Fair enough — but that defense also removes the excuse, and leaves only execution.

Why cheap book is not the same as cheap stock

Steven Klinsky's core pitch is valuation. He repeated that “NMFC continues to be oversold with the stock trading at approximately 65% of book value.” — Steven Klinsky, Chairman of NMFC and CEO of New Mountain Capital · 2026-11-03 At that price the stock would need roughly $345 million of further depreciation — about 15% of the portfolio at fair value — for book to fall to where the shares trade, and the dividend yields about 14%. The stock itself has spent the last three months flat to down, sitting about 10% below its mid-August high. The counterweight is that book value has been eroding, not compounding. NAV fell $0.22 this quarter, roughly $0.12 from higher discount rates on leveraged loans and $0.10 from company-specific marks — Insight Software, DCA Dental and RLG. The heat map moved the wrong way: green ratings fell to 86% from 88%, yellow rose from 10.2% to 11.7%. And the earnings base the discount is measured against is thin — price to trailing net income of 55.7x, up roughly 425% year over year, against quarterly net income of $18M that is a rebound from two loss-making quarters in late 2025. Thirty-five percent off book is a bargain only if the book holds. The tell is the buyback. With shares at a deep discount, repurchases have decelerated sharply — $57M in Q1, then $15M, $28M and $9M — while the company instead priced a $150M private placement that funded October 1 and originated a token $10M against $44M of sales and repayments. Leverage is not the constraint: liabilities at 57.2% of assets, down 1 point over four years, with net debt-to-equity at 1.15x against a 1.00–1.25x target. If the equity is truly 35% undervalued, the marginal dollar should go there. It is not going there. The credit soft spot is also a recurring one. DCA Dental was among the quarter's marks, and John Kline characterized it the way the company has for years: “on the dental side, I think the issues are less consumer and more operational.” — John R. Kline, Unknown - likely IR or senior management · 2026-11-03 That echoes the August 2025 diagnosis that dental is “a business that's very operationally intensive and does really require excellent execution.” — Laura C. Holson Boswerger, COO · 2025-08-05 Consistent, and consistently unforgiving. The genuine consumer exposure, per management, is low-ticket car wash and veterinary — defensive niches rather than cyclical ones.

What to watch

Three things. First, whether the rate tailwind quantifies — the forward curve now prices hikes, and a floating-rate book with matched liabilities should show it in NII within a quarter or two. Second, whether strategic priority number one finally produces a closing rather than a "line of sight." Third, whether a 65%-of-book price ever tempts a buyback that is actually sized to it. The rate story changed this quarter. The exit story has not, and that is the whole dossier in one sentence.